Natalizumab (intravenous route) - Mayo Clinic
2024年4月1日 · Natalizumab may cause a rare condition called immune reconstitution inflammatory syndrome (IRIS). This may occur after a person stops receiving this medicine after developing PML during treatment. Tell your doctor right away if you have an inflammatory reaction to an infection that includes mild burning, stinging, or tingling of the skin, or a ...
Natalizumab-sztn (intravenous route) - Mayo Clinic
Natalizumab-sztn injection is used to treat the relapsing forms (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) of multiple sclerosis (MS). This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease.
Natalizumab-Sztn (Intravenous Route) Precautions - Mayo Clinic
Natalizumab-sztn may increase the risk of developing encephalitis, meningitis, or acute retinal necrosis caused by herpes and varicella viruses. Check with your doctor if you have a fever, headache, eye pain or redness, sensitivity of the eyes to the sun, or confusion.
Monomethyl fumarate (oral route) - Mayo Clinic
2024年1月31日 · Description. Monomethyl fumarate is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Multiple sclerosis - Symptoms and causes - Mayo Clinic
2024年11月1日 · Multiple sclerosis is a disease that causes breakdown of the protective covering of nerves. Multiple sclerosis can cause numbness, weakness, trouble walking, vision changes and other symptoms.
Dalfampridine (oral route) - Mayo Clinic
Description. Dalfampridine is used to help improve walking in patients with multiple sclerosis. This medicine is a potassium channel blocker.
Infliximab (intravenous route) - Mayo Clinic
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of infliximab injection for the treatment of . Crohn disease or ulcerative colitis in children 6 years of age and older.
Esclerosis múltiple - Diagnóstico y tratamiento - Mayo Clinic
2022年12月24日 · Natalizumab (Tysabri). Es un anticuerpo monoclonal que, como se ha demostrado, disminuye el índice de recaídas y retrasa el riesgo de discapacidad. Este medicamento está diseñado para bloquear el movimiento de células inmunitarias potencialmente nocivas desde el torrente sanguíneo hacia el cerebro y la médula espinal.
Albuterol side effects: Can I avoid them? - Mayo Clinic
2023年8月29日 · Albuterol sulfate. IBM Micromedex. https://www.micromedexsolutions.com. Accessed Aug. 2, 2023. Drug treatment of asthma.
Multiple sclerosis - Diagnosis and treatment - Mayo Clinic
2024年11月1日 · Natalizumab is designed to block the movement of potentially damaging immune cells from your bloodstream to your brain and spinal cord. It may be considered a first-line treatment for some people with relapsing-remitting MS or as a second-line treatment in others.